CHGCF News and Press, Chugai Pharmaceutical From 07/25/19

Chugai Pharmaceutical ( OTCPK:CHGCF ): 1H GAAP EPS of ¥126.35. More news on: Chugai Pharmaceutical Co., Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2019 Earnings Conference Call April 24, 2019, 05:00 AM ET Company Participants Tatsuro Kosaka - President & CEO Tadahiko Sato - VP, Head of Kansai Regional Toshiaki Itagaki - VP and GM of IT Supervisory Division & Finance & A...

Chugai Pharmaceutical ( OTCPK:CHGCF ): FY EPS of ¥169.08. Revenue of ¥579.78B (+8.5% Y/Y). Press Release More news on: Chugai Pharmaceutical Co., Ltd., Earnings news and commentary, Healthcare stocks news,

A Phase 3 clinical trial, SAkuraSky Study , evaluating Chugai Pharmaceutical's ( OTCPK:CHGCF ) satralizumab as add-on therapy in patients with neuromyelitis optica spectrum disorder (NMOSD) met the primary endpoint. The results were presented at ECTRIMS in Berlin. More news on: Chugai Pha...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q2 earnings Read more ...

This article is the second of two parts discussing Alexion Pharmaceuticals ( ALXN ) and its competition. Make sure to check out Part 1 here if you have not already. In Part 2 I will focus mostly on ALXN’s competition. I have previously reviewed a large number of ALXN’s compet...

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2018 Results Conference Call April 24, 2018 02:00 AM ET Executives Toshiaki Itagaki - VP and GM of IT Supervisory Division & Finance & Accounting Department Minoru Hirose - Department Manager-R&D Portfolio Analysts Atsush...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q1 earnings Read more ...

Chugai Pharmaceutical ( OTCPK:CHGCF ): Q1 EPS of ¥51.00 More news on: Chugai Pharmaceutical Co., Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...

Foundation Medicine (NASDAQ: FMI ) announces that Chugai Pharmaceutical Ltd. ( OTCPK:CHGCF ) will broaden patient access to Foundation Medicine’s comprehensive genomic profiling (CGP) services for individuals with advanced cancer. More news on: Foundation Medicine, Inc., Chug...